Drug · DIN 02446138
RIZATRIPTAN ODT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 13, 2018; first marketed October 7, 2015.
- Drug Identification Number (DIN)
- 02446138
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 10, 2017: NOC 19895Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- October 5, 2015: NOC 17344Abbreviated New Drug Submission (ANDS) · Licensing agreemment between two companies
Other DINs named RIZATRIPTAN ODT
- DIN 02442906 · Marketed
- DIN 02442914 · Marketed
- DIN 02446111 · Marketed
- DIN 02405415 · Cancelled Pre Market
- DIN 02405423 · Cancelled Pre Market